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Abstract 
AIM: We aimed to investigate several parameters after the in vivo acute and sub-acute administration of ethanolic 
extracts from E. alsinoides & C. asiatica. 
METHODS: Malignant Ovarian Germ Cell Tumors for in vivo toxicity study guidelines 423 and 407 of Organization 
for Economic Co-operation and Development (OECD) were followed for acute and sub-acute toxicity assays 
respectively. For LD50 evaluation, a single dose of ethanolic extracts of Evolvulus alsinoides L. (EEA) and 
ethanolic extracts of Centella asiatica (ECA) was orally administered to mice at doses of 200, 400, 800, 1600 and 
2000 mg/kg. Then the animals were observed for 72 hours. For acute toxicity evaluation, a single dose of both 
extracts was orally administered to mice at doses of 300, 600, 1200 and 2000 mg/kg and the animals were 
observed for 14 days. In the sub-acute study, the extracts were orally administered to mice for 28 days at doses 
of 300, 600, 1200 and 2000 mg/kg. To assess the toxicological effects, animals were closely observed on general 
behaviour, clinical signs of toxicity, body weight, food and water intake. At the end of the study, it was performed 
biochemical and hematological evaluations, as well as histopathological analysis from the following organs: brain, 
heart, liver, and kidney. 
RESULTS: The oral administration of E. alsinoides and C. asiatica ethanolic extracts, i.e. EEA 300, EEA 600, 
EEA 1200, EEA 2000, ECA 300, ECA 600, ECA 1200 & ECA 2000 mg/kg doses showed no moral toxicity effect 
in LD50, acute and sub-acute toxicity parameters. 
CONCLUSION: In this study, we had found that E. alsinoides & C. asiatica extract at different doses cause no 
mortality in acute and sub-acute toxicity study. Also, histopathology of kidney, liver, heart, and brain showed no 
alterations in tissues morphology. 
 
 
 
 
 
 
Introduction 
 
Centella asiatica belonging to the family: 
Apiaceae is native to most of the Asian countries. 
Being herbaceous, it contains stems which are long, 
filiform and prostrate with long internodes containing 
roots, 1-5 leaves per node which are 50-350 cm in 
radius, uninformed, deeply cordate, long-petioled and 
oval or orbicular in shape, 3-6 small flowers which are 
purple to white-green in color and are arranged in 
umbels arising from the axis of the leaves. Centella 
asiatica grows well in both tropical and sub-tropical 
countries. The pharmacological activity of Centella 
asiatica is due to several active constituents including 
kaempferol-3-o-β-d-glucuronide, quercetin-3-o-β-d-
glucuronide, castillicetin, apigenin, rutin, luteolin, 
naringin [1], [2] rosmarinic acid, chlorogenic acid, 3,4-
di-o-caffeoyl quinic acid, 1,5-di-o-caffeoyl quinic acid, 
3,5-di-o-caffeoyl quinic acid, 4,5-di-o-caffeoyl quinic 
acid, isochlorogenic acid, asiaticoside, centelloside, 
madecassoside, brahmoside, brahminoside (saponin 
glycosides), asiaticentoic acid, centellic acid, 
madecassic acid, terminolic acid and betulic acid [3]. 
The plant Centella asiatica has been reported 
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as traditionally used for various ailments including 
wound healing, bronchitis, asthma, diabetes, allergy, 
cancer, diuretic, and hypertension and to improve 
mental ability [4], [5], [6], [7].  
Evolvulus alsinoides L. (Family: 
Convolvulaceae) is a small genus composed of about 
10–15 species widely distributed in Asian and 
American countries, with some of its species used 
medicinally. Evolvulus alsinoides is one of the several 
well-known Ayurvedic crude drugs that have a 
significant place in the traditional medicinal system of 
India due to its memory enhancing properties. In 
Evolvulus alsinoides some active chemical 
constituents present like triacontane, 
pentatriacontane, evolving, β-sitosterol, two alkaloids 
betaine and shankpushpin, caffeic acid, 6-methoxy-7-
O-b-glucopyranoside coumarin, kaempferol-7-O-b-
glucopyranoside, kaempferol-3-O-b-glucopyranoside 
and kaempferol-3-O-b-glucopyranoside and 
quercetine- 3-O-b-glucopyra-noside in this species [8]. 
This plant has some traditional 
pharmacological activities such as gastro protective 
[9], antibacterial [10], antiulcer
 
[11], 
immunomodulatory
 
[12], cytoprotective
 
[13], 
adaptogenic and antiamnesic
 
[14], anxiolytic
 
[15], 
diabetes
 
[16], syphilis
 
[17], tonic to brain strength & 
memory enhancer
 
[18], analgesic and anti-
inflammatory activity
 
[19]. 
We aimed to investigate several parameters 
after the in vivo acute and sub-acute administration of 
ethanolic extracts from E. alsinoides & C. asiatica. 
 
 
 
Material and Methods 
 
Plant material 
Whole plant material of Centella asiatica and 
Evolvulus alsinoides were collected from village 
Ramnapur, Varanasi, Uttar Pradesh, India in October 
2015 and authentication was done by Department of 
Botany, Banaras Hindu University, India and also 
herbarium of Evolvulus alsinoides (voucher specimen 
no. Convolvul./03/2015) and Centella asiatica 
(voucher specimen no. Apia/02/2015) plants were 
deposited in the Department of Botany, Banaras 
Hindu University, India. 
 
Preparation of extracts 
The extraction of both plants was done with 
soxhlet method in ethanolic solvents at 72-82°C for 72 
hours. The Soxhlet extraction has widely been used 
for extracting valuable bioactive compounds from 
various natural sources. It is used as a model for the 
comparison of new extraction alternatives. Generally, 
a small amount of dry sample is placed in a thimble. 
The thimble is then placed in distillation flask which 
contains the solvent of particular interest. After 
reaching an overflow level, the solution of the thimble-
holder is aspirated by a syphon.  
Syphon unloads the solution back into the 
distillation flask. This solution carries extracted solutes 
into the bulk liquid. The solute has remained in the 
distillation flask, and solvent passes back to the solid 
bed of plant. The process repeatedly runs until the 
extraction is completed. Per cent yield for Centella 
Asiatica and Evolvulus alsinoides were 16.7% w/w 
and 15.3% w/w respectively. 
 
Preparation of extract samples 
Ethanolic extracts of E. alsinoides (EEA) and 
C. asiatica (ECA) were solubilized in distilled water to 
obtain solutions of 30, 60, 120 and 200 mg/ml. The 
doses were evaluated as 300, 600, 1200 and 2000 
mg/kg. 
 
Toxicity assays 
The safety parameters assessed by 
conducting the acute and sub-acute toxicity study 
according to the OECD guidelines
 
[20] 423 and 407 
respectively. 
 
Animals 
The experimental Swiss albino mice (male 
and female) 7-8-week-old of 25-30 gm weight were 
issued by Animal house of Institute of Medical 
Sciences, Banaras Hindu University Varanasi, Uttar 
Pradesh. Animals were divided into experimental 
groups, housed in plastic cages and maintained on a 
12-hour light and 12-hour dark cycle. They were given 
standard food and water ad libitum. The Central 
Animal Ethical Committee of Banaras Hindu 
University approved all experimental procedures 
(CAEC/196). 
 
LD 50 assay 
LD50 (Lethal Dose) is the amount of a drug or 
extracts given at once, which causes the death of 
50% population of test animals. This is one way to 
measure the short-term toxicity of the drug or extract. 
For LD50 a single dose of ethanolic extracts of both 
plants Centella asiatica and Evolvulus alsinoides L. 
was orally administered to mice at doses of 200, 400, 
800, 1600 and 2000 mg/kg. Then the animals were 
observed for 72 hours. 
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Acute toxicity assay 
The animals were divided into nine 
experimental groups of 6 animals each (3 male and 3 
female). Group 1 received 10 µl/g of distilled water 
and served as control.  
Groups 2 to 5 treated with ethanolic extract of 
E. alsinoides (EEA) at the doses of 300, 600, 1200 
and 2000 mg/kg.  
Groups 6 to 9 were treated 
with ethanolic extract of C. asiatica (ECA) at doses of 
300, 600, 1200 and 2000 mg/kg respectively.  
All treatments were administered once by oral 
gavage. Animals were closely observed for 4 hours 
following administration and once a day for 14 days 
on general behaviour, clinical signs of toxicity, 
mortality, food and water intake. Body weight was 
measured before and after administration on days 4, 
7, 10 and 14. At the end of the experiment, animals 
were anaesthetized with ketamine (20 mg/kg i.p.). 
After the anaesthesia has reached depth, the cardiac 
puncture was performed to collect blood for 
biochemical and haematological evaluations. 
 
Sub-acute toxicity assay 
The animals were divided into nine 
experimental groups of 6 animals each (3 male and 3 
female). Group 1 received 10 µl/g of distilled water 
and served as control.  
Groups 2 to 5 treated with ethanolic extract of 
E. alsinoides (EEA) at the doses of 300, 600, 1200 
and 2000 mg/kg.  
Groups 6 to 9 were treated 
with ethanolic extract of C. asiatica (ECA) at doses of 
300, 600, 1200 and 2000 mg/kg respectively. 
 All treatments were administered once by 
oral gavage daily 7 days each week for 28 days. 
Animals were closely observed for 28 days on general 
behaviour, clinical signs of toxicity, mortality, food and 
water intake. Body weight was measured before and 
after administration on days 7, 14, 21 and 28. At the 
end of the experiment, animals were anaesthetised 
with ketamine (20 mg/kg i.p.). After the anaesthesia 
has reached depth, the cardiac puncture was 
performed to collect blood for biochemical and 
haematological evaluations. 
 
Haematological analysis  
The haematological evaluation was performed 
in all surviving animals at the end of the experiment. 
The complete blood count was performed using an 
automated haematology analyser. Haematological 
evaluations included haemoglobin concentration 
(HGB), red blood cell count (RBC), platelet count 
(PLT), hematocrit (HCT), mean corpuscular volume 
(MCV), mean corpuscular haemoglobin (MCH), mean 
corpuscular haemoglobin concentration (MCHC) and 
white blood cell count (WBC). 
 
Blood serum biochemistry analysis 
The biochemical evaluation was performed in 
all surviving animals at the end of the experiment. The 
collected blood was transferred to tubes without 
anticoagulant and allowed to stand for 60 min at room 
temperature and centrifuged at 4000 rpm for 10 min. 
The serum from each blood sample was recovered 
and stored in cryogenic tubes at -80°C deep freezer. 
Urea, Creatinine, Serum glutamic oxaloacetic 
transaminase (SGOT), Serum glutamic pyruvic 
transaminase (SGPT) and alkaline phosphatase were 
evaluated. 
 
Histopathology 
The organs were collected from all surviving 
animals, washed with saline solution 0.9% (w/v), 
weight and fixed in 40% formaldehyde solution. Then 
organs were processed for paraffin embedding. Five 
μm thick sections were prepared and stained with 
hematoxylin and eosin (H&E). The tissues were 
analysed in an optical microscope for their general 
structure, signs of inflammation, degenerative 
changes and necrosis evidence. The images were 
captured with the microscope Motic B1 series, 
scanned through micro camera Moticam 480 using 
the Motic Images Plus 2.0ML Application Suite 
software. 
 
Statistical analysis 
The relative haematological and biochemical 
data were expressed as mean ± standard error of the 
mean (SEM). Data were submitted to analysis of 
variance (one-way ANOVA) followed by Dunnett's 
multiple comparison tests. The results were 
expressed as mean ± SEM. The software GraphPad 
Prism 6.0 (GraphPad Software, USA) was used for 
statistical analysis. P < 0.05 were considered 
statistically significant. 
 
 
Results 
 
Acute toxicity & Sub-acute toxicity 
General signs and mortality 
No deaths were recorded within 72 hours in 
LD50 assay after administration of the extracts. No 
signs of toxicity were observed in animal groups after 
the treatment with EEA 300, EEA 600, EEA 1200, 
EEA 2000, ECA 300, ECA 600, ECA 1200 and ECA 
2000 mg/kg.  
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Body weight, relative organ weight, food 
and water intake 
 
Animal treated with EEA and ECA at the three 
evaluated doses showed weight gain throughout the 
entire experiment duration. The increase was the 
same in treated and control group animals, and the 
treatment did not affect relative organs weights, food, 
and water intake (Table 1). 
 
Table: 1 List of different parameters and general signs 
assessed during toxicity study 
Parameters Dose (mg/kg) 
EEA 
300 
EEA 
600 
EEA 
1200 
EEA 
2000 
ECA 
300 
ECA 
600 
ECA 
1200 
ECA 
2000 
Body weight N N N N N N N N 
Feed Intake N N N N N N N N 
Water Intake N N N N N N N N 
Fur Condition N N N N N N N N 
Nails Colour N N N N N N N N 
Eye Colour N N N N N N N N 
Convulsion N N N N N N N N 
Locomotion N N N N N N N N 
Dysponea N N N N N N N N 
Sedation N N N N N N N N 
Aggressive 
Behavior 
N N N N N N N N 
(Normal = N, Abnormal = Ab). 
 
 
Table: 2 Hematological parameters of Swiss mice treated for 28 days with different doses (300, 600, 1200 and 2000 mg/kg) of 
ethanolic extracts of E. alsinoides (EEA) and C. asiatica (ECA) n = 6 swiss albino mice.  
Groups 
Haematological parameters 
HGB 
(g/dL) 
RBC 
(10
6
 /µL) 
PLT 
(10
3
/µL) 
HCT 
(%) 
MCV 
(fL) 
MCH 
(pg) 
MCHC 
(g/dL) WBC (10
3
/µL) 
Control 12.3 ± 0.28 6.30 ± 0.30 901.2 ± 17.2 41.2 ± 1.09 57.0 ± 0.99 19.5 ± 0.50 32.1 ± 1.01 5.94 ± 0.20 
EEA 300 13.0 ± 0.46 6.90 ± 0.17 771.3 ± 39.8 39.6 ± 1.07 54.0 ± 0.36 17.2 ± 0.72 31.3 ± 1.65 5.85 ± 0.55 
EEA 600 12.7 ± 0.28 6.24 ± 0.24 936.4 ± 41.0 41.7 ± 1.06 57.4 ± 1.56 20.4 ± 1.06 33.7 ± 1.61 5.89 ± 0.42 
EEA 1200 12.93 ± 0.73 6.46 ± 0.44 928.8 ± 23.8 43.66 ± 1.45 57.1 ± 0.96 19.26 ± 0.76 32.56 ± 0.63 5.48 ± 0.63 
EEA 2000 13.33 ± 0.63 7.06 ± 0.69 795.9 ± 26.1 43.16 ± 2.00 57.20 ± 1.83 20.33 ± 1.80 31.86 ± 1.68 5.51 ± 0.39 
ECA 300 13.63 ± 0.52 7.22 ± 0.31 816.1 ± 10.2 41.52 ± 1.29 55.09 ± 1.09 18.75 ± 1.10 30.77 ± 1.21 5.46 ± 0.29 
ECA 600 12.6 ± 0.3 6.66 ± 0.24 795.7 ± 9.1 39.2 ± 0.46 53.43 ± 0.66 16.86 ± 0.17 28.36 ± 1.53 4.89 ± 0.16 
ECA 1200 13.5 ± 0.4 7.25 ± 0.5 862.5 ±14.7 45.5 ± 1.9 55.8 ± 0.8 18.8 ± 0.7 32.9 ± 0.7 5.27 ± 0.5 
ECA 2000 13.6 ± 0.57 7.46 ± 0.78 784.3 ± 25.5 46.2 ± 1.12 57.5 ± 1.47 20.8 ± 1.28 33.5 ± 0.40 5.79 ± 0.21 
One-way ANOVA followed by Dunett’s multiple comparison tests. *p < 0.05, **p < 0.01, ***p < 0.001. Abbreviations: Hemoglobin concentration (HGB), Red blood cell count (RBC), platelet 
count (PLT), hematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC) and white blood cell count 
(WBC). 
 
Haematological parameters 
Treatment with EEA and ECA at all doses did 
not produce any changes on animal haematological 
parameters. 
 
Biochemical parameter 
Treatment with EEA and ECA at all doses did 
not produce any statistically significant changes on 
Urea, Creatinine, SGOT, SGPT and alkaline 
phosphatase (Table 3). 
Table 3: Blood serum biochemical parameters of Swiss albino 
mice treated with dosage (300, 600, 1200 & 2000 mg/kg) of 
ethanolic extracts of E. alsinoides & C. asiatica. N = 6 swiss 
albino mice.  
Groups 
Urea 
Normal value = 
25-30 mg/dl 
Creatinine 
Normal value = 
0.2-0.9 mg/dl 
SGOT 
Normal value = 
54-298 mg/dl 
SGPT 
Normal value = 
17-77 mg/dl 
Alkaline 
phosphatase 
Normal value = 
35-96 mg/dl 
Normal 26.80 ± 1.12 0.3 ± 0.06 57.92 ± 1.62 58.18 ± 3.22 39.41 ± 3.22 
EEA 300 26.54 ± 0.82 0.4 ± 0.08 58.59 ± 4.19 52.69 ± 1.11 55.45 ± 4.76 
EEA 600 27.45 ± 0.62 0.6 ± 0.1 55.19 ± 2.06 62.67 ± 6.26 46.51 ± 5.73 
EEA 1200 27.68 ± 0.68 0.4 ± 0.08 55.26 ± 1.30 59.10 ± 2.8 48.87 ± 2.05 
EEA 2000 27.88 ± 0.82 0.4 ± 0.12 61.82 ± 4.28 51.45 ± 8.93 54.38 ± 3.33 
ECA 300 27.38 ± 1.02 0.5 ± 0.13 55.08 ± 0.57 63.82 ± 5.79 51.54 ± 4.08 
EAC 600 26.33 ± 0.68 0.4 ± 0.12 56.24 ± 1.24 52.80 ± 1.77 55.55 ± 5.08 
ECA 1200 27.36 ± 1.80 0.5 ± 0.05 58.24 ± 2.00 59.36 ± 3.56 41.32 ± 3.69 
ECA 2000 26.24 ± 0.83 0.2 ± 0.03 57.94 ± 4.51 57.49 ± 2.53 50.82 ± 2.08 
One-way AVOVA followed by Dunett’s multiple comparison test. *p < 0.05, **p < 0.01, ***p 
< 0.001. 
 
Histopathological analysis 
The oral administration of ECA and EEA did 
not produce significant dose-dependent 
Histopathological alterations. At the four evaluated 
doses, it was not observed any tissue damage on the 
kidney, heart, liver and brain of mice.  
 
             (a) Normal                     (b) EEA                       (c) ECA 
Figure 1: Histopathological slides of kidney organ shown no 
changes in Swiss albino mice treated with (b) EEA & (c) ECA 
extracts 
Microscopic histological slides from different 
organs of Swiss albino mice treated with ethanolic 
extracts of E. alsinoides & C. asiatica, i.e. EEA & ECA 
respectively are shown in Figures 1 to 4. 
 
             (a) Normal                    (b) EEA                        (c) ECA 
Figure 2: Histopathological slides of heart organ shown no changes 
in Swiss albino mice treated with (b) EEA & (c) ECA extracts 
 
 
Discussion 
 
To assess preliminary toxicity study animal 
models are widely used because the early 
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identification of side effects is usually predictive of the 
toxicity in humans and can save time, resources and 
efforts
 
[21]. In this study, several parameters 
evaluated after the in vivo acute and sub-
acute administration of ethanolic extracts from E. 
alsinoides & C. asiatica were investigated. In 
toxicological evaluation mortality is an 
important criterion
 
[22] and there was no mortality 
seen in both acute and sub-acute evaluation of 
extracts. For LD50 no death was recorded in 72 hours 
of administration of extracts. 
 
              (a) Normal                   (b) EEA                          (c) ECA 
Figure 3: Histopathological slides of LIVER organ shown no 
changes in Swiss albino mice treated with (b) EEA & (c) ECA 
extracts 
 
In acute toxicity, no death was recorded in 14 
days extracts administration and in sub-acute toxicity 
study also no death recorded for 28 days extract 
administration. Clinical signs of toxicity were observed 
after the acute administration and during the sub-
acute evaluation for all extract dosage. Liver damage 
is usually assessed by the determination of SGOT, 
SGPT, and alkaline phosphatase.  
 
             (a) Normal                      (b) EEA                        (c) ECA 
Figure 4: Histopathological slides of brain organ shown no changes 
in Swiss albino mice treated with (b) EEA & (c) ECA extracts 
 
It was not observed any significant alterations 
in serum levels of these three markers of liver function 
after acute and sub-acute administration of extracts 
and histopathological analysis did not show liver 
damage. Renal function was evaluated by serum 
levels of urea, creatinine and by histological analysis.  
The histopathological evaluation did not 
reveal alterations in this organ of any treated groups 
of sub-acute toxicity. Also, no tissue alterations found 
in the heart and brain of animals treated with 28 
days E. alsinoides & C. asiatica extracts.  
In this study, we had found 
that E. alsinoides & C. asiatica extracts at different 
doses cause no mortality in acute and sub-acute 
toxicity study. In addition, histopathology of kidney, 
liver, heart, and brain showed no alterations in tissues 
morphology.  
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